ArticleVeterinary sciences2026
Case Report of a Rare Clinical Presentation of Craniomaxillofacial Osteosarcoma in an Adult Male Dog.
Article in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 8-year-old intact male German Shorthaired Pointer presented as a referral for a one-week history of unilateral ocular discharge of the left eye and progressive temporalis muscle atrophy. Severe temporalis muscle wasting was appreciated, with periorbital asymmetry. Computed tomography showed aggressive and extensive multifocal bone lysis, primarily on the left rostral aspect of the skull, affecting the cribriform plate, frontal bone, ethmoid bone, zygomatic bone, and maxilla, with marked left temporal muscle atrophy and near-complete collapse and destruction of the left frontal sinus. Bone biopsy revealed osteoblastic osteosarcoma of the skull. Aside from the physical examination abnormalities, the patient did not exhibit pain, lethargy or anorexia at home or while in hospital. This case is notable for the unusual presentation, clinical manifestation and location of osteoblastic osteosarcoma in dogs. The survival time of 132 days was calculated starting from the date of confirmed histopathologic diagnosis, or 159 days from the date of the computed tomography scan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.